Laminopathies, caused by mutations in the LMNA gene encoding the nuclear envelope proteins lamins A and C, represent a diverse group of diseases that include Emery-Dreifuss muscular dystrophy (EDMD), dilated cardiomyopathy (DCM), limb-girdle muscular dystrophy, and Hutchison-Gilford progeria syndrome 1 . Most LMNA mutations affect skeletal and cardiac muscle by mechanisms that remain incompletely understood. Loss of structural function and altered interaction of mutant lamins with (tissue-specific) transcription factors have been proposed to explain the tissue-specific phenotypes 1 . Here we report in mice that lamin-A/C-deficient (Lmna 2/2 ) and Lmna N195K/N195K mutant cells have impaired nuclear translocation and downstream signalling of the mechanosensitive transcription factor megakaryoblastic leukaemia 1 (MKL1), a myocardin family member that is pivotal in cardiac development and function 2 . Altered nucleo-cytoplasmic shuttling of MKL1 was caused by altered actin dynamics in Lmna 2/2 and Lmna N195K/N195K mutant cells. Ectopic expression of the nuclear envelope protein emerin, which is mislocalized in Lmna mutant cells and also linked to EDMD and DCM, restored MKL1 nuclear translocation and rescued actin dynamics in mutant cells. These findings present a novel mechanism that could provide insight into the disease aetiology for the cardiac phenotype in many laminopathies, whereby lamin A/C and emerin regulate gene expression through modulation of nuclear and cytoskeletal actin polymerization.
MKL1 (also known as MAL or MRTF-A) is a mechanosensitive transcription factor with important roles in the cardiovascular system 2, 3 . Intracellular localization of MKL1 is regulated via changes in actin polymerization 4, 5 . Normally, MKL1 is localized in the cytoplasm by binding to cytoplasmic G actin and constitutive nuclear export. Mitogenic or mechanical stimulation triggers RhoA-mediated actin polymerization, liberating MKL1 from G actin and exposing a nuclear localization sequence (NLS) within the actin-binding domain of MKL1 (refs 6, 7) . Increased nuclear import, coupled with decreased export, causes accumulation of MKL1 in the nucleus, where it co-activates serum response factor (SRF) to turn on genes regulating cellular motility and contractility, including vinculin, actin and SRF itself 8 . Because cells from lamin-A/ C-deficient mice have impaired activation of mechanosensitive genes in vitro 9 and in vivo 10 , we investigated whether loss of lamin A/C could affect MKL1-SRF signalling. Nuclear translocation of endogenous MKL1 in response to serum stimulation was severely abrogated in Lmna 2/2 mouse embryonic fibroblasts (MEFs) compared to wild-type controls (Fig. 1a, c and Supplementary Fig. 1a ). We confirmed these findings by time-lapse microscopy of cells expressing MKL1-green fluorescent protein (GFP) (Figs 1b and 2a) and in lamin-A/C-downregulated HeLa cells ( Supplementary Fig. 2a, b ), indicating that impaired MKL1 translocation is a general effect of loss of lamin A/C. To test whether similar defects could also result from lamin mutations associated with DCM, we investigated cells from the Lmna N195K/N195K mouse model (subsequently referred to as Lmna N195K cells), which develops severe DCM but lacks skeletal muscle involvement 11 ( Fig. 1a-c and Supplementary Fig. 1a ) and bone-marrow-derived mesenchymal stem cells ( Supplementary Fig. 1b ) had impaired nuclear translocation of MKL1. Notably, cardiac sections from Lmna 2/2 and Lmna N195K/N195K mice had significantly reduced fractions of cardiomyocytes with nuclear MKL1 (Fig. 1d, e ), confirming MKL1 translocation defects in vivo and implicating altered MKL1 signalling in the development of cardiomyopathies in these animals.
To characterize the consequences of altered MKL1 translocation, we assessed expression of select MKL1-SRF target genes. Lmna 2/2 and Lmna N195K MEFs had impaired serum-induced expression of Srf and vinculin ( Fig. 1f , g) and had fewer focal adhesions than wild-type controls ( Supplementary Fig. 3c, d) ; expression of an SRF-dependent luciferase reporter was also significantly reduced ( Supplementary Fig. 3e ). Cardiac tissues from Lmna 2/2 mice had lower Srf and actin transcript levels than those from wild-type littermates, and activation of Srf expression in response to left ventricular pressure overload was impaired in Lmna 1/2 mice (Fig. 1h , i and Supplementary Fig. 3a, b ), demonstrating altered MKL1-SRF mechanosignalling in vivo.
Experiments with an NLS-GFP-NES reporter construct consisting of GFP fused to an NLS and a nuclear export sequence (NES) revealed that general nuclear import and export were preserved in Lmna 2/2 and Lmna N195K cells ( Supplementary Fig. 4 ), as were levels and localization of the nuclear transport factor Ran and its regulator, RCC1 ( Supplementary Fig. 2c-f ). We then devised experiments to assess independently nuclear import and export of MKL1. Nuclear import was measured by monitoring nuclear accumulation of MKL1-GFP while blocking nuclear export with leptomycin B 8 . Lmna 2/2 and Lmna N195K mutant cells had significantly reduced nuclear import of MKL1 in response to serum stimulation than wild-type controls ( Fig. 2b) , which we confirmed with photoactivatable MKL1-PAGFP ( Supplementary Fig. 5 ; see also Supplementary Videos 7-9). Fluorescence loss in photobleaching (FLIP) experiments revealed that lamin mutant MEFs had a significantly faster decrease in nuclear MKL1-GFP ( Fig. 2c ) than wild-type cells, indicating increased nuclear export of MKL1 in Lmna 2/2 and mutant MEFs.
Nuclear import and export of MKL1 are regulated by actin polymerization 8 , requiring interaction between MKL1 and G actin via three aminoterminal RPEL motifs 12 . We expressed a truncated MKL1 construct, MKL1(1-204)-23GFP, which contains the RPEL motifs but lacks the transcriptional domains ( Fig. 2d ) and recapitulates the actin-binding characteristics and serum-inducible translocation of full-length MKL1 (ref. 12 ). Nuclear accumulation of MKL1(1-204)-23GFP was substantially Lmna 
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lower in Lmna 2/2 and Lmna N195K cells than in wild-type cells ( Fig. 2e , f), indicating that impaired nuclear translocation of MKL1 was caused by altered actin dynamics in the lamin mutant cells. As seen with full-length MKL1-GFP, FLIP studies showed that nuclear export of MKL1(1-204)-23GFP was significantly increased in the mutant cells ( Fig. 2g ). In contrast, abrogation of G-actin binding by mutating all three RPEL motifs (MKL1(1-204)XXX-23GFP) or disrupting the interaction between G actin and MKL1 with cytochalasin D resulted in nuclear accumulation of MKL1(1-204)XXX-23GFP ( Supplementary  Fig. 6a ) and endogenous MKL1 ( Supplementary Fig. 6b ), respectively, in all cell types, indicating that MKL1 can enter the nucleus of Lmna 2/2 and Lmna N195K cells when decoupled from actin dynamics. We subsequently compared actin organization between mutant and wild-type cells. Fluorescence recovery after photobleaching (FRAP) revealed that nuclear actin, which modulates nuclear export of MKL1 (ref. 8) , was more mobile in Lmna 2/2 cells than in wild-type controls ( Supplementary Fig. 7 ). Lmna 2/2 and Lmna N195K MEFs also had a larger fraction of highly mobile cytoplasmic actin ( Fig. 3a ). Furthermore, Lmna 2/2 and Lmna N195K cells were slower to reassemble stress fibres after disruption of actin filaments with cytochalasin D (Fig. 3b, c ). In addition, whereas wild-type cells increased their ratio of F actin to G actin upon serum stimulation, Lmna 2/2 and Lmna N195K MEFs had a consistently weaker response (Fig. 3d ). These findings indicate that actin polymerization is altered in Lmna 2/2 and Lmna N195K cells and that altered actin organization may be responsible for the impaired nuclear translocation of MKL1.
What causes disturbed actin organization in lamin mutant cells? Because lamins contribute to nucleo-cytoskeletal coupling and impaired nucleo-cytoskeletal coupling can disturb perinuclear actin organization, we tested whether disrupting nucleo-cytoskeletal coupling with dominant-negative nesprin mutants (consisting of the KASH domain of nesprin) could reproduce defects in MKL1 translocation. However, expression of dominant-negative KASH had no effect on MKL1 localization ( Supplementary Fig. 8 ). Emerin, an inner nuclear membrane protein associated with X-linked EDMD 13 , is an actin pointed-end capping protein that promotes actin polymerization in vitro 14 and requires lamin A/C for proper localization. In Lmna 2/2 and Lmna N195K MEFs, emerin was more mobile and mislocalized from the nuclear envelope compared with wild-type cells ( Fig. 4a and Supplementary  Fig. 9a ). Hemizygous emerin-null male mice (Emd 2/Y ) MEFs displayed the same impaired nuclear translocation of MKL1 as lamin mutant cells, which could be rescued by re-introduction of exogenous emerin ( Fig. 4b-d ). FRAP studies in Emd 2/Y MEFs demonstrated that exogenous emerin completely restored actin mobility to levels of wild-type cells (Fig. 4e, f) . Ectopic expression of emerin also markedly improved nuclear translocation of MKL1 in Lmna 2/2 and Lmna N195K cells ( Fig. 4d and Supplementary Fig. 9b ) by increasing the amount of emerin available at the nuclear envelope. In contrast, expression of emerin mutants unable to bind actin and to promote actin polymerization 14 failed to restore nuclear translocation of MKL1 and caused dominantnegative defects in wild-type cells (Fig. 4d ). These data indicate that emerin is a crucial modulator of actin polymerization and that loss of emerin from the nuclear envelope causes disturbed actin dynamics and impaired MKL1 signalling.
Taken together, our data suggest a novel mechanism for nuclear envelope proteins to regulate MKL1-SRF signalling by modulating actin polymerization. We propose that emerin primarily affects nuclear actin polymerization, which controls nuclear export and transcriptional activity of MKL1 (refs 2, 8) . Altered MKL1-SRF signalling could then further affect cytoskeletal actin, as MKL1 and SRF are master regulators for numerous cytoskeletal proteins, including actin and actin-binding proteins, consistent with the reduced cytoskeletal stiffness reported in Lmna 2/2 MEFs 9,15,16 . Given the low levels of emerin at the outer nuclear membrane 17 and the fact that the fraction of emerin at the endoplasmic reticulum increases in Lmna 2/2 and Lmna N195K cells (Supplementary Fig. 10 ), it is likely that emerin has only a limited direct effect on cytoplasmic actin polymerization. Nonetheless, we cannot exclude the possibility that emerin (and lamins) may have additional effects on MKL1. For example, direct interaction of lamin A/C with nuclear G actin 18 could further contribute to the altered actin dynamics in Lmna 2/2 and Lmna N195K cells, as lamins, together with emerin and spectrin IIa, may form a nuclear cortical actin network 14 . Furthermore, emerin can inhibit or reduce the nuclear accumulation of other transcription factors, including b-catenin, Lmo7 and phospho-ERK1/2 (ref. 19 ).
Lmna 2/2 and Lmna N195K/N195K mice develop DCM and have defects in cytoskeletal organization and focal adhesions 9,20,21 , consistent with impaired MKL1-SRF signalling 22 . Underscoring the crucial role of MKL1-SRF in cardiac function, cardiac-specific deletion of SRF in adult mice results in DCM 23 . Considering the marked similarity of the cardiac phenotype observed in these mice with those in EDMD and DCM patients, we propose that impaired MKL1-SRF signalling and the resulting alterations in cytoskeletal organization may have a pivotal role in the development of cardiac defects and muscle phenotypes in various laminopathies. Surprisingly, although Emd 2/Y cells have obvious defects in nuclear stability and mechanotransduction signalling 24, 25 , emerin-deficient mice-unlike human patients with emerin mutations -lack an overt muscular phenotype 26 , indicating additional layers of complexity, species-specific differences, and possible compensation in the Emd 2/Y mice. Nonetheless, Emd 2/Y animals show delays in muscle repair 26 , consistent with a role of MKL1 in satellite cells and skeletal muscle regeneration 27 and providing additional support for the involvement of impaired MKL1 signalling in nuclear envelopathies. 
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Our findings further illustrate the wide-ranging impacts of mutations in nuclear envelope proteins. Treatment of lamin and emerin mutant mice with MAPK inhibitors can reduce cardiac and skeletal phenotypes 28 , which may be attributed at least in part to the effect on MKL1 signalling, as inhibiting ERK1/2 activity is expected to increase nuclear localization of MKL1 by reducing its nuclear export 20 . These findings encourage further approaches to correct impaired MKL1-SRF signalling to ameliorate the devastating cardiac disease associated with many laminopathies.
METHODS SUMMARY
Details for standard cell biology techniques (western blotting, immunofluorescence labelling, time-lapse microscopy and photobleaching experiments) can be found in the Methods. Mouse models have been described previously 11, 26, 29 . All animal work was conducted in accordance with relevant guidelines and regulations. 
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METHODS
Plasmids. MKL1-GFP was a gift from A. Kapus; MKL1(1-204)-23GFP, MKL1 (1-204)XXX-23GFP, NLS-GFP-NES and MKL1-PAGFP were obtained from M. Vartiainen. The NLS-GFP-NES reporter construct consists of GFP fused to an NLS and an importin a/b-dependent NES, using the same import/export mechanism as MKL1 (ref. 30 ). The MKL1(1-204)XXX-23GFP construct contains alanine substitutions in all three of the MKL1 RPEL motifs, which abrogates binding to G actin and leads to constitutively nuclear localization independent of actin polymerization 12 . GFP-RCC1 was obtained from B. Paschal. GFP-actin was from F. Gertler and emerin-GFP was obtained from H. Worman. Lamin and emerin mouse models. Lmna 2/2 mice along with heterozygous (Lmna 1/2 ) and wild-type (Lmna 1/1 ) littermates were obtained from crossing Lmna 1/2 mice. Similarly, Lmna N195K/N195K and heterozygous (Lmna N195K/1 ) and wild-type (Lmna 1/1 ) littermates resulted from breeding Lmna N195K/1 animals. Lmna 2/2 mice develop severe muscular dystrophy and cardiomyopathy and die at 4-8 weeks of age 29 . Lmna N195K/N195K mice develop severe dilated cardiomyopathy and die prematurely around 12-16 weeks of age 11 . Genotype was determined by polymerase chain reaction of genomic tail DNA, as described previously 29 . The mouse colonies were derived from breeders provided by C. Stewart 11, 26, 29 . All mice were maintained in the animal facility at Cornell University following protocols approved by the Cornell University Institutional Animal Care and Use Committee (IACUC Antibodies and immunofluorescence staining. Goat anti-MKL1 (C-19 and H-180), goat anti-actin (C-11) conjugated with horseradish peroxidase (HRP) and goat anti-lamin A/C (N-18) antibodies were purchased from Santa Cruz Biotechnology. Mouse anti-Ran antibody (610341) was purchased from BD Biosciences. Mouse anti-emerin antibody (NCL-emerin) was a product from Novocastra. Mouse anti-paxillin (05-417) was purchased from Millipore. Rabbit anti-tubulin (ab6046) was purchased from Abcam. Secondary antibodies conjugated to Alexa-488 or Alexa-568 fluorophores were purchased from Molecular Probes (Invitrogen). For immunofluorescence staining, cells grown at subconfluency were collected and fixed with 4% paraformaldehyde/phosphate-buffered saline (PBS) and permeabilized with 0.2% Triton X-100 in PBS for 10 min at room temperature. Cells were grown at similar subconfluency for all cell lines tested. Primary antibodies in 4% bovine serum albumin in Tris-buffered saline (TBS) with 0.05% Tween 20 were incubated for 1 h at room temperature or overnight at 4 uC. Cells were washed three times and incubated with appropriate secondary antibodies for 1 h at room temperature. Slides were mounted in Prolong Gold Anti-Fade medium with 49,6-diamidino-2-phenylindole (DAPI) (Molecular Probes, Invitrogen). Images were collected and analysed on a Zeiss LSM 700 confocal microscope (Carl Zeiss). Images were captured using identical exposure times for each cell line. Real-time PCR was carried out using SYBR-Green technology (Applied Biosystems) in a total volume of 25 ml. Gene expression for Srf and Vcl was quantified. Values were normalized to an endogenous control, TATA binding protein (Tbp), and compared to unstimulated samples with the DDC t method. Data are based on results from three independent experiments. SRE-luciferase assay. SRF forms a complex over the SRE/CArG element upon receiving upstream signals from the MAPK pathway and/or the RhoA pathway. SRE activity was measured using the Dual-Glo SRE-Luciferase Assay (Promega) according to manufacturer's instructions. Briefly, Lmna 1/1 , Lmna 2/2 and Lmna N195K MEFs were transfected with either the SRE reporter construct or positive and negative controls. Dual-luciferase data from starved and serum-stimulated transfected cells were then collected on a luminometer. The fold change of SRE activity for each cell line was determined by comparing normalized luciferase activities of the reporter in stimulated versus starved samples. Time-lapse microscopy and photobleaching experiments. For live cell imaging, a Zeiss LSM 700 confocal microscope (Carl Zeiss) equipped with a 363 oil immersion objective (Carl Zeiss) was used. Cells were maintained at 37 uC in HEPES-buffered DMEM for the duration of the time-lapse acquisition. Images were recorded at 30 s or 1 min intervals and analysed using the Zen software (Carl Zeiss).
For photobleaching experiments, cells were plated on a coverslip and mounted onto a glass slide with a depression containing culture media. Fluorescence loss in photobleaching (FLIP) experiments were performed on a Zeiss LSM 700 confocal microscope (Carl Zeiss) using the 488 nm laser line. Cells had been serum-stimulated for 30 min before the experiments. Relative loss in nuclear fluorescence during continuous photobleaching of cytoplasmic MKL1-GFP was computed by normalizing nuclear fluorescence intensity to pre-bleach values (t 5 0). Increased loss of nuclear fluorescence indicates a higher rate of nuclear export of MKL1-GFP. For FLIP experiments, two single scans were acquired, followed by repeated photobleaching using a single bleach pulse at intervals of 1 s for 200 iterations in defined regions of approximately 30 mm 2 in the cytoplasm. Single section images were then collected at 1 s intervals. For imaging, the laser power was attenuated to 2% of the bleach intensity. The relative fluorescence intensity in a region of interest was determined by normalizing fluorescence intensity in the region to the total fluorescence in the same region during prebleach. This method provides a means of quantifying nuclear export as the cytoplasmic pool of fluorescent protein is rapidly bleached and subsequent loss of fluorescence signal from the nucleus reflects nuclear export. For FRAP experiments, the cells were scanned
